cadez T, Macek Hrvat N, Sinko G, Kalisiak J, Radic Z, Fokin V
Arch Toxicol. 2025; .
PMID: 40032685
DOI: 10.1007/s00204-025-03985-6.
Knittelova K, Prchalova E, Fuchsova A, Andrys R, Kohoutova Z, Rademacherova S
ACS Med Chem Lett. 2024; 15(12):2181-2189.
PMID: 39691526
PMC: 11647715.
DOI: 10.1021/acsmedchemlett.4c00464.
Foretic B, Klaser T, Ovcar J, Loncaric I, Zilic D, Santic A
Molecules. 2024; 29(23).
PMID: 39683770
PMC: 11643671.
DOI: 10.3390/molecules29235611.
Mlakic M, cadez T, Sinko G, Skoric I, Kovarik Z
Biomolecules. 2024; 14(6).
PMID: 38927082
PMC: 11201660.
DOI: 10.3390/biom14060679.
Prchalova E, Andrys R, Pejchal J, Kohoutova Z, Knittelova K, Hofmanova T
Arch Toxicol. 2024; 98(9):2937-2952.
PMID: 38789714
DOI: 10.1007/s00204-024-03791-6.
Profiling Novel Quinuclidine-Based Derivatives as Potential Anticholinesterase Drugs: Enzyme Inhibition and Effects on Cell Viability.
Zunec S, Vadlja D, Ramic A, Zandona A, Marakovic N, Brekalo I
Int J Mol Sci. 2024; 25(1).
PMID: 38203326
PMC: 10778980.
DOI: 10.3390/ijms25010155.
Strategies for enhanced bioavailability of oxime reactivators in the central nervous system.
Prchalova E, Kohoutova Z, Knittelova K, Malinak D, Musilek K
Arch Toxicol. 2023; 97(11):2839-2860.
PMID: 37642747
DOI: 10.1007/s00204-023-03587-0.
Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands.
Gaso Sokac D, Zandona A, Roca S, Vikic-Topic D, Lihtar G, Marakovic N
Int J Mol Sci. 2022; 23(21).
PMID: 36362178
PMC: 9655973.
DOI: 10.3390/ijms232113388.
Broad-Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve-Agent-Inhibited Acetylcholinesterase.
Lindgren C, Forsgren N, Hoster N, Akfur C, Artursson E, Edvinsson L
Chemistry. 2022; 28(40):e202200678.
PMID: 35420233
PMC: 9400889.
DOI: 10.1002/chem.202200678.
PBDEs Found in House Dust Impact Human Lung Epithelial Cell Homeostasis.
Zandona A, Jagic K, Dvorscak M, Madunic J, Klincic D, Katalinic M
Toxics. 2022; 10(2).
PMID: 35202283
PMC: 8874582.
DOI: 10.3390/toxics10020097.
Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides.
Kohoutova Z, Malinak D, Andrys R, Svobodova J, Psotka M, Schmidt M
J Enzyme Inhib Med Chem. 2022; 37(1):760-767.
PMID: 35193448
PMC: 8881075.
DOI: 10.1080/14756366.2022.2041628.
Activation of (un)regulated cell death as a new perspective for bispyridinium and imidazolium oximes.
Zandona A, Marakovic N, Misetic P, Madunic J, Mis K, Padovan J
Arch Toxicol. 2021; 95(8):2737-2754.
PMID: 34173857
DOI: 10.1007/s00204-021-03098-w.
Development of versatile and potent monoquaternary reactivators of acetylcholinesterase.
Gorecki L, Hepnarova V, Zdarova Karasova J, Hrabinova M, Courageux C, Dias J
Arch Toxicol. 2021; 95(3):985-1001.
PMID: 33517499
DOI: 10.1007/s00204-021-02981-w.
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates.
Lee H, Andrys R, Jonczyk J, Kim K, Vishakantegowda A, Malinak D
J Enzyme Inhib Med Chem. 2021; 36(1):437-449.
PMID: 33467931
PMC: 7822067.
DOI: 10.1080/14756366.2020.1869954.
Counteracting poisoning with chemical warfare nerve agents.
Macek Hrvat N, Kovarik Z
Arh Hig Rada Toksikol. 2021; 71(4):266-284.
PMID: 33410774
PMC: 7968514.
DOI: 10.2478/aiht-2020-71-3459.
Pharmacokinetics of Two Chlorine-Substituted Bis-Pyridinium Mono-Aldoximes with Regenerating Effect on Butyrylcholinesterase.
Kalasz H, Szimrok Z, Karvaly G, Adeghate J, Tekes K
Molecules. 2020; 25(5).
PMID: 32164301
PMC: 7179459.
DOI: 10.3390/molecules25051250.
Synthesis, screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators.
Malinak D, Dolezal R, Hepnarova V, Hozova M, Andrys R, Bzonek P
J Enzyme Inhib Med Chem. 2020; 35(1):478-488.
PMID: 31910701
PMC: 6968506.
DOI: 10.1080/14756366.2019.1710501.
Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.
Macek Hrvat N, Kalisiak J, Sinko G, Radic Z, Sharpless K, Taylor P
Toxicol Lett. 2019; 321:83-89.
PMID: 31863869
PMC: 7053431.
DOI: 10.1016/j.toxlet.2019.12.016.
In Vitro Evaluation of Neutral Aryloximes as Reactivators for Acetylcholinesterase Inhibited by Paraoxon.
Kitagawa D, Cavalcante S, de Paula R, Rodrigues R, Bernardo L, da Silva M
Biomolecules. 2019; 9(10).
PMID: 31597234
PMC: 6843506.
DOI: 10.3390/biom9100583.